428 related articles for article (PubMed ID: 22033521)
1. Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast.
Treusch S; Hamamichi S; Goodman JL; Matlack KE; Chung CY; Baru V; Shulman JM; Parrado A; Bevis BJ; Valastyan JS; Han H; Lindhagen-Persson M; Reiman EM; Evans DA; Bennett DA; Olofsson A; DeJager PL; Tanzi RE; Caldwell KA; Caldwell GA; Lindquist S
Science; 2011 Dec; 334(6060):1241-5. PubMed ID: 22033521
[TBL] [Abstract][Full Text] [Related]
2. A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity.
D'Angelo F; Vignaud H; Di Martino J; Salin B; Devin A; Cullin C; Marchal C
Dis Model Mech; 2013 Jan; 6(1):206-16. PubMed ID: 22888099
[TBL] [Abstract][Full Text] [Related]
3. Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1-42) compared to Aβ(1-40).
Wesén E; Jeffries GDM; Matson Dzebo M; Esbjörner EK
Sci Rep; 2017 May; 7(1):2021. PubMed ID: 28515429
[TBL] [Abstract][Full Text] [Related]
4. Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis.
Xiao Q; Gil SC; Yan P; Wang Y; Han S; Gonzales E; Perez R; Cirrito JR; Lee JM
J Biol Chem; 2012 Jun; 287(25):21279-89. PubMed ID: 22539346
[TBL] [Abstract][Full Text] [Related]
5. Alterations in endocytic protein expression with increasing age in the transgenic APP695 V717I London mouse model of amyloid pathology: implications for Alzheimer's disease.
Thomas RS; Alsaqati M; Bice JS; Hvoslef-Eide M; Good MA; Kidd EJ
Neuroreport; 2017 Oct; 28(15):963-968. PubMed ID: 28885485
[TBL] [Abstract][Full Text] [Related]
6. In vivo dynamics of clathrin and its adaptor-dependent recruitment to the actin-based endocytic machinery in yeast.
Newpher TM; Smith RP; Lemmon V; Lemmon SK
Dev Cell; 2005 Jul; 9(1):87-98. PubMed ID: 15992543
[TBL] [Abstract][Full Text] [Related]
7. PICALM and Alzheimer's Disease: An Update and Perspectives.
Ando K; Nagaraj S; Küçükali F; de Fisenne MA; Kosa AC; Doeraene E; Lopez Gutierrez L; Brion JP; Leroy K
Cells; 2022 Dec; 11(24):. PubMed ID: 36552756
[TBL] [Abstract][Full Text] [Related]
8. Clathrin-mediated endocytic proteins are upregulated in the cortex of the Tg2576 mouse model of Alzheimer's disease-like amyloid pathology.
Thomas RS; Lelos MJ; Good MA; Kidd EJ
Biochem Biophys Res Commun; 2011 Dec; 415(4):656-61. PubMed ID: 22079091
[TBL] [Abstract][Full Text] [Related]
9. Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity.
Matlack KE; Tardiff DF; Narayan P; Hamamichi S; Caldwell KA; Caldwell GA; Lindquist S
Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4013-8. PubMed ID: 24591589
[TBL] [Abstract][Full Text] [Related]
10. Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer's Disease.
Alsaqati M; Thomas RS; Kidd EJ
J Gerontol A Biol Sci Med Sci; 2018 Mar; 73(3):289-298. PubMed ID: 28655199
[TBL] [Abstract][Full Text] [Related]
11. Partial loss of CALM function reduces Aβ42 production and amyloid deposition in vivo.
Kanatsu K; Hori Y; Takatori S; Watanabe T; Iwatsubo T; Tomita T
Hum Mol Genet; 2016 Sep; 25(18):3988-3997. PubMed ID: 27466196
[TBL] [Abstract][Full Text] [Related]
12. The Role of PICALM in Alzheimer's Disease.
Xu W; Tan L; Yu JT
Mol Neurobiol; 2015 Aug; 52(1):399-413. PubMed ID: 25186232
[TBL] [Abstract][Full Text] [Related]
13. Regulators of yeast endocytosis identified by systematic quantitative analysis.
Burston HE; Maldonado-Báez L; Davey M; Montpetit B; Schluter C; Wendland B; Conibear E
J Cell Biol; 2009 Jun; 185(6):1097-110. PubMed ID: 19506040
[TBL] [Abstract][Full Text] [Related]
14. AIP-1 ameliorates beta-amyloid peptide toxicity in a Caenorhabditis elegans Alzheimer's disease model.
Hassan WM; Merin DA; Fonte V; Link CD
Hum Mol Genet; 2009 Aug; 18(15):2739-47. PubMed ID: 19414486
[TBL] [Abstract][Full Text] [Related]
15. In vivo induction of membrane damage by β-amyloid peptide oligomers.
Julien C; Tomberlin C; Roberts CM; Akram A; Stein GH; Silverman MA; Link CD
Acta Neuropathol Commun; 2018 Nov; 6(1):131. PubMed ID: 30497524
[TBL] [Abstract][Full Text] [Related]
16. A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting Aβ
Xu J; Yuan Y; Zhang R; Song Y; Sui T; Wang J; Wang C; Chen Y; Guan S; Wang L
Bioorg Chem; 2019 Feb; 82():332-339. PubMed ID: 30428413
[TBL] [Abstract][Full Text] [Related]
17. The protein architecture of the endocytic coat analyzed by FRET microscopy.
Skruzny M; Pohl E; Gnoth S; Malengo G; Sourjik V
Mol Syst Biol; 2020 May; 16(5):e9009. PubMed ID: 32400111
[TBL] [Abstract][Full Text] [Related]
18. Decreased CALM expression reduces Aβ42 to total Aβ ratio through clathrin-mediated endocytosis of γ-secretase.
Kanatsu K; Morohashi Y; Suzuki M; Kuroda H; Watanabe T; Tomita T; Iwatsubo T
Nat Commun; 2014 Feb; 5():3386. PubMed ID: 24577224
[TBL] [Abstract][Full Text] [Related]
19. Generation of the amyloid-beta peptide N terminus in Saccharomyces cerevisiae expressing human Alzheimer's amyloid-beta precursor protein.
Greenfield JP; Xu H; Greengard P; Gandy S; Seeger M
J Biol Chem; 1999 Nov; 274(48):33843-6. PubMed ID: 10567340
[TBL] [Abstract][Full Text] [Related]
20. Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.
Tian Y; Chang JC; Fan EY; Flajolet M; Greengard P
Proc Natl Acad Sci U S A; 2013 Oct; 110(42):17071-6. PubMed ID: 24067654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
